GlassScriptPhysician profile
Sheela O Isikwe
NPI 1144600610
$1,200.92
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,186 · 2022: $14.55.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $476.81 | 2021 | |
| Viiv Healthcare Company | $353.35 | 2021 | |
| Janssen Biotech, INC. | $96.51 | 2021 | |
| Merck Sharp & Dohme LLC | $83.34 | 2021 | |
| Emd Serono, INC. | $50.50 | 2021 | |
| Theratechnologies INC. | $32.31 | 2021 | |
| Janssen Products, LP | $31.49 | 2021 | |
| Abbvie INC. | $30.23 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Napo Pharmaceuticals INC | $17.90 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheela Isikwe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.